Mar 09, 2022 / 01:40PM GMT
Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Senior Research Associate
Great. Sorry for the delay, everybody. I'm Andrew Cooper, diagnostics analyst here at Raymond James. Happy to be joined by Mike Brophy, CFO of Natera. Hi, guys. And without any further ado, let's jump right into it. I'll hand it over to Mike to give us just an overview of Natera and some of the moving parts in the landscapes you play in.
Michael Brophy - Natera, Inc. - CFO
Yes, good. Thanks for the time. I appreciate seeing everyone in person. We're kind of back here a little bit. That's great. So Natera, as many of you know, has really one core technology that's fueled a couple of different businesses for us. The largest of which is the women's health business, which is powered by Panorama, our non-invasive prenatal monitoring test. That test -- the history of that test is that we were fourth to market when we launched that test back in 2013. We quickly got to the market-leading position with that test, and we just maintain that market-leading position over
Natera Inc at Raymond James Institutional Investors Conference Transcript
Mar 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers